Tofenacin
Tofenacin[edit | edit source]
Tofenacin is a tricyclic antidepressant (TCA) that was developed in the 1960s. It is primarily used in the treatment of depression and has been studied for its effects on various neurotransmitter systems in the brain.
Pharmacology[edit | edit source]
Tofenacin works by inhibiting the reuptake of norepinephrine and serotonin, two key neurotransmitters involved in mood regulation. This action increases the concentration of these neurotransmitters in the synaptic cleft, thereby enhancing neurotransmission and improving mood in patients with depression.
Chemical Properties[edit | edit source]
Tofenacin is a member of the tricyclic antidepressant class, characterized by its three-ring chemical structure. The chemical structure of Tofenacin is depicted in the image to the right. This structure is crucial for its ability to interact with neurotransmitter transporters in the brain.
Clinical Use[edit | edit source]
Tofenacin is prescribed for the treatment of major depressive disorder. It is typically administered orally and dosage is adjusted based on the patient's response and tolerance to the medication. Like other TCAs, Tofenacin may take several weeks to exhibit its full therapeutic effects.
Side Effects[edit | edit source]
Common side effects of Tofenacin include dry mouth, constipation, urinary retention, and blurred vision. These effects are due to its anticholinergic properties. Patients may also experience drowsiness, weight gain, and orthostatic hypotension.
Mechanism of Action[edit | edit source]
Tofenacin's primary mechanism of action is the inhibition of the reuptake of norepinephrine and serotonin. By blocking the transporters responsible for the reuptake of these neurotransmitters, Tofenacin increases their availability in the synaptic cleft, which is thought to contribute to its antidepressant effects.
History[edit | edit source]
Tofenacin was developed in the 1960s during a period of extensive research into tricyclic antidepressants. It was one of several compounds synthesized to improve the efficacy and reduce the side effects associated with earlier antidepressants.
Related Pages[edit | edit source]
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
